Primovist 5 ml. 7.5 ml. 10 ml Solution for injection
PDF Leaflet Revision Date: 14 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Gadolinium-based contrast agent for MRI of the liver.
Dosage (summary)
0.1 ml/kg body weight as an intravenous bolus injection.
Onset of Action / Duration
Onset: 10 mins, Duration: 120 mins.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Use only if clinically necessary; minimal excretion in breast milk.
Key Drug Interactions
- OATP inhibitors
- Elevated bilirubin levels
Contraindications
- Hypersensitivity to active substance or excipients
Common side effects
- Nausea
- Headache
- Dizziness
- Increased blood pressure
Counselling Points
- Avoid intramuscular injection
- Post-procedure observation recommended
- Inform about potential allergic reactions
Serious warnings
- Risk of anaphylactoid reactions
- Monitor patients with cardiac disorders
Important Disclaimer
The Primovist 5 ml. 7.5 ml. 10 ml Solution for injection professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
